An Efficient Synthesis of 1-(1,3-Dioxoisoindolin-2-yl)-3-aryl Urea Analogs as Anticancer and Antioxidant Agents: An Insight into Experimental and <i>In Silico</i> Studies

An Efficient Synthesis of 1-(1,3-Dioxoisoindolin-2-yl)-3-aryl Urea Analogs as Anticancer and Antioxidant Agents: An Insight into Experimental and <i>In Silico</i> Studies

The present investigation reports the efficient multistep synthesis of 1-(1,3-dioxoisoindolin-2-yl)-3-aryl urea analogs (<b>7a</b>–<b>f</b>) in good yields. All the 1-(1,3-dioxoisoindolin-2-yl)-3-aryl urea analogs (<b>7a</b>–<b>f</b>) were characterize...

Full description

Bibliographic Details
Main Authors:	Obaid Afzal, Mohamed Jawed Ahsan
Format:	Article
Language:	English
Published:	MDPI AG 2023-12-01
Series:	Molecules
Subjects:	ADMET anticancer antioxidant cell lines phthalimide molecular docking
Online Access:	https://www.mdpi.com/1420-3049/29/1/67

Similar Items

Synthesis, in Vivo and in Silico Studies of N-Aryl-4-(1,3-Dioxoisoindolin-2-Yl)Benzamides as an Anticonvulsant Agent
by: Parisa Kiminejad Malaie, et al.
Published: (2020-03-01)

New Derivatives of 5-((1-Methyl-Pyrrol-2-yl) Methyl)-4-(Naphthalen-1-yl)-1,2,4-Triazoline-3-Thione and Its Coordination Compounds with Anticancer Activity
by: Agnieszka Czylkowska, et al.
Published: (2022-08-01)

The 2-hydroxy-3-(4-aryl-1-piperazinyl)propyl Phthalimide Derivatives as Prodrugs—Spectroscopic and Theoretical Binding Studies with Plasma Proteins
by: Aleksandra Marciniak, et al.
Published: (2022-06-01)

Crystal structures of 2-[3,5-bis(bromomethyl)-2,4,6-triethylbenzyl]isoindoline-1,3-dione and 2-{5-(bromomethyl)-3-[(1,3-dioxoisoindolin-2-yl)methyl]-2,4,6-triethylbenzyl}isoindoline-1,3-dione
by: Manuel Stapf, et al.
Published: (2021-09-01)

Synthesis, Anticancer Activity, and In Silico Studies of 5-(3-Bromophenyl)-<i>N</i>-aryl-4<i>H</i>-1,2,4-triazol-3-amine Analogs
by: Mohamed Jawed Ahsan, et al.
Published: (2023-10-01)

Synthesis and Evaluation of Anti-acetylcholinesterase Activity of 2-(2-(4-(2-Oxo-2-phenylethyl)piperazin-1-yl) ethyl)Isoindoline-1,3-dione Derivatives with Potential Anti-Alzheimer Effects
by: Alireza Aliabadi, et al.
Published: (2013-10-01)

Microwave-Assisted Facile Synthesis, Anticancer Evaluation and Docking Study of N-((5-(Substituted methylene amino)-1,3,4-thiadiazol-2-yl)methyl) Benzamide Derivatives
by: Shailee V. Tiwari, et al.
Published: (2017-06-01)

Synthesis and Anticancer Evaluation of 4-Chloro-2-((5-aryl-1,3,4-oxadiazol-2-yl)amino)phenol Analogues: An Insight into Experimental and Theoretical Studies
by: Obaid Afzal, et al.
Published: (2023-08-01)

Molecular docking, drug-likeness and DFT study of some modified tetrahydrocurcumins as potential anticancer agents
by: Ahmed Mahal, et al.
Published: (2024-01-01)

A New N-Substituted 1<i>H</i>-Isoindole-1,3(2<i>H</i>)-Dione Derivative—Synthesis, Structure and Affinity for Cyclooxygenase Based on In Vitro Studies and Molecular Docking
by: Dominika Szkatuła, et al.
Published: (2021-07-01)

2-(2-(4-Benzoylpiperazin-1-yl)ethyl)isoindoline-1,3-dione derivatives: Synthesis, docking and acetylcholinesterase inhibitory evaluation as anti-alzheimer agents
by: Ahmad Mohammadi-Farani, et al.
Published: (2017-01-01)

The photodecarboxylative addition of carboxylates to phthalimides as a key-step in the synthesis of biologically active 3-arylmethylene-2,3-dihydro-1H-isoindolin-1-ones
by: Ommid Anamimoghadam, et al.
Published: (2017-12-01)

Synthesis and characterization of new phthalimides and succinimides substituted with 1,3,4-oxadiazole ring
by: Ahlam Marouf Al-Azzawi, et al.
Published: (2012-06-01)

Phthalimide Analogs Enhance Genotoxicity of Cyclophosphamide and Inhibit Its Associated Hypoxia
by: Amira M. Gamal-Eldeen, et al.
Published: (2022-04-01)

Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network Pharmacology
by: Lili Yan, et al.
Published: (2022-03-01)

Methyl 2-(1,3-dioxoisoindolin-2-yl)acrylate
by: Ya-Wen Wang, et al.
Published: (2008-01-01)

Thiazolopyrimidine as a Promising Anticancer Pharmacophore: In Silico Drug Design, Molecular Docking and ADMET Prediction Studies
by: Omar A. El-Khouly, et al.
Published: (2022-11-01)

Defining desirable natural product derived anticancer drug space: optimization of molecular physicochemical properties and ADMET attributes
by: Deepika Singh
Published: (2016-06-01)

Wnt/β‐catenin signaling pathway inhibitors, glycyrrhizic acid, solanine, polyphyllin I, crocin, hypericin, tubeimoside‐1, diosmin, and rutin in medicinal plants have better binding affinities and anticancer properties: Molecular docking and ADMET study
by: Chukwuebuka Egbuna, et al.
Published: (2023-07-01)

Novel Approaches for the Solid-Phase Synthesis of Dihydroquinazoline-2(1<i>H</i>)-One Derivatives and Biological Evaluation as Potential Anticancer Agents
by: Qiong Wang, et al.
Published: (2022-12-01)

4-[2-(1,3-Dioxoisoindolin-2-yl)-1,3-thiazol-4-yl]benzonitrile
by: K. Saravanan, et al.
Published: (2016-07-01)

Pharmaceutical and Safety Profile Evaluation of Novel Selenocompounds with Noteworthy Anticancer Activity
by: Małgorzata Anna Marć, et al.
Published: (2022-02-01)

Crystal structure of 2,2′-{[(2-nitrobenzyl)azanediyl]bis(propane-3,1-diyl)}bis[1H-isoindole-1,3(2H)-dione]
by: Ryne Holmberg, et al.
Published: (2021-02-01)

Crystal structure of 2,2′-({[2-(tritylsulfanyl)benzyl]azanediyl}bis(ethane-2,1-diyl))bis(isoindoline-1,3-dione)
by: Ulrich Flörke, et al.
Published: (2014-09-01)

Design, synthesis and biological evaluation of aryl urea derivatives of oxazole-pyrimidine as anticancer agents
by: Veeranjaneyulu Pattabi, et al.
Published: (2024-01-01)

(2R)-2-(1,3-Dioxoisoindolin-2-yl)-3-methylbutanoic acid
by: Abdul Rauf Raza, et al.
Published: (2011-09-01)

Novel quinazolines bearing 1,3,4-thiadiazole-aryl urea derivative as anticancer agents: design, synthesis, molecular docking, DFT and bioactivity evaluations
by: Sara Masoudinia, et al.
Published: (2024-02-01)

Novel tetrahydronaphthalen-1-yl-phenethyl ureas: synthesis and dual antibacterial-anticancer activities
by: Yusuf Akbaba, et al.
Published: (2024-12-01)

2-[2-(1,3-Dioxoisoindolin-2-yl)acetamido]acetic acid
by: Moazzam H. Bhatti, et al.
Published: (2010-11-01)

Borylated 2,3,4,5-Tetrachlorophthalimide and Their 2,3,4,5-Tetrachlorobenzamide Analogues: Synthesis, Their Glycosidase Inhibition and Anticancer Properties in View to Boron Neutron Capture Therapy
by: David M. Campkin, et al.
Published: (2022-05-01)

Synthesis, crystal structure, spectroscopic, quantum chemical investigation, molecular docking and ADMET prediction of 2(E)-3-(anthracen-9-yl)-1-(1-methyl-1H-pyrrol-2-yl) prop-2-en-1-one
by: S. Srinivasan, et al.
Published: (2022-01-01)

Anticonvulsive evaluation and histopathological survey of thalidomide synthetic analogs on lithium-pilocarpine-induced status epilepticus in rats
by: Arash Amanlou, et al.
Published: (2021-01-01)

3-(1,2,3-Triazol-4-yl)-β-Carbolines and 3-(1<i>H</i>-Tetrazol-5-yl)-β-Carbolines: Synthesis and Evaluation as Anticancer Agents
by: João L. P. Ribeiro, et al.
Published: (2022-12-01)

The 1:1 adduct of caffeine and 2-(1,3-dioxoisoindolin-2-yl)acetic acid
by: Moazzam H. Bhatti, et al.
Published: (2011-09-01)

Anticancer Evaluation of 4-substituted-<i>N</i>-(quinolin-8-yl)pyridine-3-sulfonamides
by: Krzysztof Szafrański, et al.
Published: (2022-11-01)

Biological evaluation and pharmacokinetic profiling of a coumarin-benzothiazole hybrid as a new scaffold for human gliomas
by: Moustafa T. Gabr, et al.
Published: (2020-09-01)

(Z)-3&#945;-(1,3-Dioxoisoindolin-2-yl)-17(20)-pregnene
by: Yue Qi, et al.
Published: (2011-08-01)

Synthesis, characterization and anticancer evaluation of 2-(naphthalen-1-ylmethyl/naphthalen-2-yloxymethyl)-1-[5-(substituted phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-1H-benzimidazole
by: Salahuddin, et al.
Published: (2014-09-01)

Green Synthesis of Soluble Polysilsesquioxane with Phthalimide Groups
by: Artem I. Emel’yanov, et al.
Published: (2023-12-01)

Naphthalene Phthalimide Derivatives as Model Compounds for Electrochromic Materials
by: Magdalena Zawadzka, et al.
Published: (2023-02-01)